A set of charts, again thanks to DD for preparing these, reflecting the course of the epidemic which now covers well over a year. A lot has changed, including testing regimens, vaccination and treatment options, which affect the events-cases, hospitalizations and deaths–reflected in these charts in ways that are hard to analyze in light of the poor data transparency from the state. But you can see that testing is at about the same level. Cases are beginning what appears to be a swing back up, albeit from a very low level. Hospitalizations I would be very cautious about comparing for two reasons. One is the remdesivir treatment requires a hospitalization even if the patient doesn’t otherwise need it. We may also have more short term admissions for observation or antibody infusions. And we know that for breakthrough infections at least half of admissions attributed to CV-19 were not because of CV-19, but just people who test positive on admission. I think the same is likely true for non-vaxed admissions. Deaths remain low, and while they lag, it definitely appears that vaccines have cut the risk of death, even in the frail elderly.
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
Research
MedPAC 2019 Report to Congress
June 18, 2019
Headlines
Tags
Access
ACO
Care Management
Chronic Disease
Comparative Effectiveness
Consumer Directed Health
Consumers
Devices
Disease Management
Drugs
EHRs
Elder Care
End-of-Life Care
FDA
Financings
Genomics
Government
Health Care Costs
Health Care Quality
Health Care Reform
Health Insurance
Health Insurance Exchange
HIT
HomeCare
Hospital
Hospital Readmissions
Legislation
M&A
Malpractice
Meaningful Use
Medicaid
Medical Care
Medicare
Medicare Advantage
Mobile
Pay For Performance
Pharmaceutical
Physicians
Providers
Regulation
Repealing Reform
Telehealth
Telemedicine
Wellness and Prevention
Workplace
Related Posts
Commentary
April 25, 2024
Uh-oh, the Economic Crap Hits the Fan
The economy is slowing and inflation accelerating while productivity declines. What a great combination.
Commentary
April 25, 2024
Another of Your Regular US Debt Sales Updates
The five-year US Treasury note runs into resistance in a weaker auction than that for…